PE20020232A1 - Bacterias acido lacticas como lactobacillus, bifidobacterium y streptococcus aisladas por su potencial probiotico para aplicaciones de alimento de mascotas - Google Patents

Bacterias acido lacticas como lactobacillus, bifidobacterium y streptococcus aisladas por su potencial probiotico para aplicaciones de alimento de mascotas

Info

Publication number
PE20020232A1
PE20020232A1 PE2001000477A PE2001000477A PE20020232A1 PE 20020232 A1 PE20020232 A1 PE 20020232A1 PE 2001000477 A PE2001000477 A PE 2001000477A PE 2001000477 A PE2001000477 A PE 2001000477A PE 20020232 A1 PE20020232 A1 PE 20020232A1
Authority
PE
Peru
Prior art keywords
bifidobacterium
lactic acid
acid bacteria
lactobacillus
pets
Prior art date
Application number
PE2001000477A
Other languages
English (en)
Inventor
Roberto Reniero
Florence Rochat
Eduardo Schiffrin
Pablo Perez
Ralf Zink
Christoph Cavadini
Der Wei Thierry Von
Jalil Benyacoub
Virginie Rousseau
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of PE20020232A1 publication Critical patent/PE20020232A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/42—Dry feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/23—Lactobacillus acidophilus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/805—Pet food for dog, cat, bird, or fish

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Husbandry (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Fodder In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE REFIERE A CEPAS AISLADAS DE BACTERIAS DE ACIDO LACTICO COMO LACTOBACILLUS REUTERI; L. ACIDOPHILUS, L. ANIMALS, L. RUMINIS, L. JOHNSONII, L. CASEI, L. PARACASEI, L. RHAMNOSUS, L. FERMENTUM, BIFIDOBACTERIUM sp, ENTEROCCUS FAECIUM QUE TIENEN AFINIDAD PROBIOTICA; SELECCIONADAS POR SU CAPACIDAD PARA SOBREVIVIR Y COLONIZAR EL TRACTO GASTROINTESTINAL DE MASCOTAS, QUE TIENE CAPACIDAD DE CRECER PRODUCIENDO AL MENOS 1.OE +06 cfu/ml EN LA PRESENCIA DE HASTA 2% DE SALES BILIARES; DESPUES DE 2 HORAS A UN INTERVALO DE pH DE 3,4 A 4,2. LOS PROBIOTICOS PUEDEN SER UTILES PARA EL TRATAMIENTO Y PROFILAXIS DE TRASTORNOS ASOCIADOS CON LA COLONIZACION DEL TRACTO INTESTINAL EN MASCOTAS POR MICROORGANISMOS PATOGENOS, REGULAR EL SISTEMA DE PELAJE DE MASCOTAS, MEJORA O REDUCCION DE LOS EFECTOS DE ENVEJECIMEINTO EN MASCOTAS
PE2001000477A 2000-05-25 2001-05-24 Bacterias acido lacticas como lactobacillus, bifidobacterium y streptococcus aisladas por su potencial probiotico para aplicaciones de alimento de mascotas PE20020232A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201867 2000-05-25
EP01201503 2001-04-25

Publications (1)

Publication Number Publication Date
PE20020232A1 true PE20020232A1 (es) 2002-04-16

Family

ID=26072297

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000477A PE20020232A1 (es) 2000-05-25 2001-05-24 Bacterias acido lacticas como lactobacillus, bifidobacterium y streptococcus aisladas por su potencial probiotico para aplicaciones de alimento de mascotas

Country Status (24)

Country Link
US (5) US7189390B2 (es)
EP (2) EP1290136B1 (es)
JP (2) JP4343477B2 (es)
KR (1) KR100796963B1 (es)
CN (1) CN100396769C (es)
AR (1) AR029100A1 (es)
AT (1) ATE325864T1 (es)
AU (2) AU2001278432B2 (es)
BR (1) BR0111275B1 (es)
CA (1) CA2409286C (es)
DE (2) DE60127731T2 (es)
EA (1) EA006428B1 (es)
ES (2) ES2284089T3 (es)
HU (1) HU230800B1 (es)
IL (2) IL152695A0 (es)
MX (1) MXPA02011595A (es)
MY (1) MY138070A (es)
NO (1) NO330276B1 (es)
NZ (1) NZ523010A (es)
PE (1) PE20020232A1 (es)
PL (1) PL207930B1 (es)
UY (1) UY26734A1 (es)
WO (1) WO2001090311A1 (es)
ZA (1) ZA200210302B (es)

Families Citing this family (124)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US7608291B2 (en) * 2000-03-10 2009-10-27 Mars, Inc. Treatment of infection in animals
BR0111275B1 (pt) * 2000-05-25 2013-06-18 uso de probiàtico para preparar composiÇço para regular o sistema imune, composiÇço alimentÍcia para animais de estimaÇço, e complemento de dieta.
US20040028665A1 (en) 2002-01-08 2004-02-12 Garner Bryan E. Compositions and methods for inhibiting pathogenic growth
US7291326B2 (en) 2003-01-06 2007-11-06 Nutrition Physiology Corporation Compositions and methods for reducing the pathogen content of meat and meat products
GB0212975D0 (en) 2002-06-06 2002-07-17 Mars Uk Ltd Mammalian animal composition
US8168170B2 (en) * 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
US20040197304A1 (en) * 2003-04-01 2004-10-07 The Procter & Gamble Company And Alimentary Health, Ltd. Methods of determining efficacy of treatments of inflammatory diseases of the bowel
RU2006101616A (ru) 2003-06-20 2006-07-27 Ньютриниа Лтд. (Il) Способ защиты биоактивных соединений и композиции, содержащие указанные соединения
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US20050119222A1 (en) 2003-12-01 2005-06-02 The Iams Company Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
US20050118234A1 (en) * 2003-12-01 2005-06-02 The Iams Company Methods and kits related to administration of a fructooligosaccharide
EP1706126A4 (en) * 2003-12-04 2009-07-01 Biofilms Strategies Inc METHODS AND COMPOSITIONS FOR PREVENTING FORMATION OF BIOFILMS, REDUCTION OF EXISTING BIOFILMS, AND REDUCTION OF BACTERIA POPULATIONS
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
JP2005224108A (ja) * 2004-02-10 2005-08-25 Yamahisa:Kk ペット用スナックフード
GB0406654D0 (en) * 2004-03-24 2004-04-28 Mars Inc Foodstuff
EP1758464A4 (en) * 2004-05-24 2012-10-24 Nutrinia Ltd NUTRITIONAL FOOD AND SUPPLEMENT, ITS COMPOSITION, PROCESSING AND METHOD FOR ITS USE
KR100595528B1 (ko) * 2004-08-21 2006-07-03 전덕영 내산성, 내산소성 및 내염성이 우수한 비피도박테리움 아니말리스 ｄｙ－６４ 및 이를 함유한 식품
EP1634948A1 (en) 2004-09-10 2006-03-15 Basf Aktiengesellschaft Means and methods for preventing and/or treating caries
DE602004013441T2 (de) * 2004-09-21 2009-06-04 Nestec S.A. Verbesserung der Lebensdauer alter Katzen
US20100233312A9 (en) * 2005-04-11 2010-09-16 The Procter & Gamble Company Compositions comprising probiotic and sweetener components
US20060228448A1 (en) * 2005-04-11 2006-10-12 The Iams Company Pet food compositions comprising two components
PL1885383T3 (pl) * 2005-05-31 2017-06-30 Iams Europe B.V. Kocie probiotyczne bifidobakterie
AU2006253006B8 (en) * 2005-05-31 2011-09-15 Alimentary Health Ltd Feline probiotic Lactobacilli
AU2011202947B2 (en) * 2005-05-31 2011-11-03 Alimentary Health Ltd Feline probiotic lactobacilli
ITMI20051137A1 (it) * 2005-06-17 2006-12-18 Ista S P A Metodo per prevenire l'inattivazione da parte di batteriofagi specifici di miscele di ceppi probiotici utilizzati negli allevamenti animali
KR100720025B1 (ko) * 2005-09-27 2007-05-21 (주)바이오토피아 프로바이오틱 유산균 및 이를 포함하는 조성물
US20070280964A1 (en) * 2005-10-06 2007-12-06 Ruth Knorr Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic FHV-1 infections, and preventing or treating conjunctivitis
ATE474585T1 (de) * 2005-10-06 2010-08-15 Nestec Sa Probiotische enterokokken für eine verbesserte immunität
JP4897426B2 (ja) * 2005-10-18 2012-03-14 花王株式会社 ペットフード
CA2624849A1 (en) * 2005-10-19 2007-04-26 Hill's Pet Nutrition, Inc. Methods and compositions for improving gastrointestinal health
ATE541469T1 (de) * 2005-12-29 2012-02-15 Hills Pet Nutrition Inc Verfahren zum modifizieren der darmflora bei tieren
CA2646196C (en) * 2006-03-29 2018-07-17 Nestec S.A. Dietary supplements containing probiotics
WO2007138993A1 (ja) * 2006-05-31 2007-12-06 Meiji Dairies Corporation 免疫調節活性の高い乳酸菌の培養法
FR2903574B1 (fr) * 2006-07-13 2008-09-05 Gervais Danone Sa Granules de cysteine et leurs utilisations a titre d'activateurs de croissance de bifidobacterium animalis lactis.
KR100720024B1 (ko) * 2006-12-20 2007-05-18 (주)바이오토피아 프로바이오틱 비피도박테리움 보움 ｒ5 균주 및 이를포함하는 조성물
PL2124966T3 (pl) 2007-02-01 2016-01-29 Iams Europe B V Sposób zmniejszania reakcji zapalnej i stresu u ssaków za pomocą antymetabolitów glukozy, awokado lub ekstraktów awokado
US7910127B2 (en) * 2007-03-02 2011-03-22 Biogaia Ab Use of lactic acid bacteria for improving food lysine absorption of pet animals
RU2476083C2 (ru) * 2007-08-29 2013-02-27 Марс, Инкорпорейтед Однопорционный корм для кошек и способы его получения
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
ES2689129T3 (es) 2009-01-02 2018-11-08 Nestec S.A. Composiciones alimenticias que tienen un aspecto, una textura y un tacto similar a la carne
WO2010096550A2 (en) * 2009-02-18 2010-08-26 University Of Florida Research Foundation, Inc. Lactobacillus supplement for alleviating type 1 diabetes
US20100233347A1 (en) 2009-03-13 2010-09-16 Uhrhan Richard B Food compositions having a realistic meat-like appearance, feel, and texture
DE102009032712A1 (de) * 2009-05-22 2010-11-25 Growth Finance Plus Ag Tierfutter
US20110027417A1 (en) * 2009-07-31 2011-02-03 Patrick Joseph Corrigan Process for Dusting Animal Food
US20110027420A1 (en) * 2009-07-31 2011-02-03 Haile Mehansho Moisture migration reduction layer for a food product
US9173423B2 (en) * 2009-07-31 2015-11-03 The Iams Company Animal food kibble with electrostatically adhered dusting
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US9210945B2 (en) * 2009-07-31 2015-12-15 The Iams Company Animal food having low water activity
US8691303B2 (en) * 2009-07-31 2014-04-08 The Iams Company Dusted animal food
FI122247B (fi) 2009-08-12 2011-10-31 Vetcare Oy Probioottinen valmiste koiran maha- ja suolistokanavassa ilmenevien häiriöiden ennaltaehkäisemiseksi tai hoitamiseksi
ES2610829T3 (es) 2009-11-11 2017-05-03 Alimentary Health Limited Cepa de Bifidobacterium
WO2011075138A1 (en) 2009-12-18 2011-06-23 Hill's Pet Nutrition, Inc. Pet food compositions including probiotics and methods of manufacture and use thereof
JP5901618B2 (ja) 2010-05-26 2016-04-13 ネステク ソシエテ アノニム カタラーゼの産生又は活性を増大させる方法
WO2012039745A1 (en) * 2010-09-23 2012-03-29 Nestec S.A. Methods and compositions for preventing or treating osteoarthritis
WO2012060884A1 (en) * 2010-11-04 2012-05-10 Nestec S.A. Methods and compositions for preventing and treating osteoarthritis
ES2565407T3 (es) 2010-11-05 2016-04-04 Nestec S.A. Procedimiento para la preparación de un producto alimenticio para animales de compañía, el cual contiene microorganismos probióticos
EP2449890A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Powdered cereal compositions comprising non-replicating probiotic microorganisms
EP2452576A1 (en) * 2010-11-11 2012-05-16 Nestec S.A. Extruded non-replicating probiotic micro-organisms and their health benefits
BR112013018453A2 (pt) * 2010-12-21 2018-05-22 Nestec Sa métodos e composições para a prevenção e tratamento de osteoartrite
RU2597793C2 (ru) 2011-01-25 2016-09-20 Нестек С.А. Способы и композиции для лечения, ослабления или предотвращения ухудшения зрительной системы животных
WO2012128982A2 (en) 2011-03-18 2012-09-27 Nestec S.A. Compositions and methods useful for ameliorating age related maladies
WO2012141876A1 (en) 2011-04-15 2012-10-18 Nestec S.A. Methods for regulating sirtuin gene expression
CN102250799B (zh) * 2011-06-22 2013-09-11 南京农业大学 草酸降解菌njode1及其应用
US20130045185A1 (en) * 2011-08-18 2013-02-21 Dupont Nutrition Biosciences Aps Strains and methods useful for mycotoxins
US9113653B2 (en) 2011-08-19 2015-08-25 Steven J Maranz Methods of administering probiotic organisms that synthesize carotenoid compounds in situ to enhance human health and nutrition
CN102399733B (zh) * 2011-12-14 2014-07-09 北京大北农科技集团股份有限公司 约氏乳杆菌及其菌剂、应用和预混料
CN102578415B (zh) * 2012-02-23 2016-01-20 北京大北农科技集团股份有限公司 约氏乳杆菌在制备提高禽类产蛋性能和蛋品质饲料中的应用
US9585925B1 (en) * 2012-05-04 2017-03-07 Vetnique Labs LLC Pet food supplement
PL2900805T3 (pl) 2012-09-25 2023-06-05 Aquilón Cyl S.L. Kompozycje probiotyczne i prebiotyczne
US10413577B2 (en) * 2013-02-22 2019-09-17 The Regents Of The University Of California Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life
CN104286408B (zh) * 2014-06-13 2017-10-24 杨雄 一种嗜酸乳杆菌xd13r制备的生物制剂在减少宠物体内抗药性细菌比例的应用方法
EP3223634A1 (en) 2014-11-25 2017-10-04 Nestec S.A. Methods and compositions for preserving lean body mass and promoting fat loss during weight loss
RU2701347C2 (ru) 2014-11-25 2019-09-25 Сосьете Де Продюи Нестле С.А. Способ и композиция для стимулирования безжировой массы тела и минимизации накопления жира в организме и управления массой
US9675667B2 (en) 2015-02-10 2017-06-13 Massachusetts Institute Of Technology Isolated mucins and different microorganisms, and methods of use
CA2975217C (en) 2015-02-13 2023-08-15 Mars, Incorporated Pet food feeding system
US11304428B2 (en) 2015-02-16 2022-04-19 Mars, Incorporated Interlocking kibble
EP3288394A4 (en) 2015-04-28 2019-01-23 Mars, Incorporated PROCESS FOR THE PREPARATION OF A STERILIZED WASTE FOOD PRODUCT
GB201520497D0 (en) * 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
RS57471B1 (sr) 2015-12-17 2018-09-28 Institut Za Molekularnu Genetiku I Geneticko Inzenjerstvo Univerzitet U Beogradu Nova probiotička starter kultura za humanu i animalnu primenu
WO2017109623A1 (en) * 2015-12-22 2017-06-29 Nestec Sa Immune health for companion animals
EA201891508A1 (ru) 2015-12-24 2019-03-29 Дэйри Э Дэй Инк. Композиции и методы применения новых штаммов lactobacillus fermentum
MX2018011512A (es) 2016-03-24 2019-02-07 Nutrinia Ltd Uso de insulina para promover el vaciamiento gástrico.
JP7183174B2 (ja) * 2017-03-15 2022-12-05 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 分岐αグルカン
US11357803B2 (en) 2017-09-22 2022-06-14 Iowa State University Research Foundation, Inc. Probiotic compositions for production of dopamine
CN107821753A (zh) * 2017-11-20 2018-03-23 江苏雅博动物健康科技有限责任公司 一种宠物用益生菌颗粒制剂及其制备方法
US10758577B2 (en) * 2017-12-14 2020-09-01 Pure Cultures 2020, Inc. Probiotics and fermentation metabolites for the prevention and treatment of disease conditions in animals
FI128916B (en) 2018-02-05 2021-03-15 Vetcare Oy Health-promoting composition and method for its preparation
KR102079794B1 (ko) * 2018-09-18 2020-02-20 전북대학교산학협력단 신규한 엔테로코커스 패시움 균주 및 이의 용도
AU2018445887B2 (en) 2018-10-18 2022-09-08 Hill's Pet Nutrition, Inc. Pet food compositions
CA3116822A1 (en) 2018-12-13 2020-06-18 Societe Des Produits Nestle Sa Methods for enhancing metabolic health in an animal
BR112021008259A2 (pt) 2018-12-13 2021-08-03 Société des Produits Nestlé S.A. métodos para aumentar a oxidação de gordura ou o gasto de energia ou a saciedade em um animal
CN111172055B (zh) * 2019-03-14 2022-06-10 南京农业大学 副干酪乳杆菌lhz-1及其在去除脱氧雪腐镰刀菌烯醇中的应用
US20220305063A1 (en) * 2019-05-30 2022-09-29 New York University Probiotic compositions and methods of use
WO2020243676A1 (en) * 2019-05-31 2020-12-03 South Dakota Board Of Regents Technology Transfer Office Probiotics to inhibit enteric pathogens
US20230063695A1 (en) * 2019-09-13 2023-03-02 Aquilon Cyl S.L. Fermented milk product for administration in canids such as dogs, and uses thereof
CL2019003739A1 (es) * 2019-12-18 2020-06-19 Univ Concepcion Cepas probióticas de lactobacillus sp. y de pediococcus sp. y su uso en la elaboración de una formulación probiótica para prevención de diarreas causadas por patógenos bacterianos que afectan a perros y gatos.
US20210186054A1 (en) 2019-12-19 2021-06-24 Société des Produits Nestlé S.A. Compositions and methods for providing a health benefit to a growing animal
JP7515153B2 (ja) 2020-03-06 2024-07-12 学校法人麻布獣医学園 乳酸菌含有組成物
CA3178133A1 (en) * 2020-05-29 2021-12-02 Julie K SPEARS Compositions and methods for digestive health in an animal
US12011468B2 (en) 2020-06-03 2024-06-18 Société des Produits Nestlé S.A. Compositions and methods for digestive health in an animal
CA3188936A1 (en) 2020-09-03 2022-03-10 Ping Yu Compositions and methods for providing health benefits in an animal
CA3188423A1 (en) 2020-09-04 2022-03-10 Francois-Pierre Martin Compositions and methods for providing health benefits in an animal
CN112266876A (zh) * 2020-11-02 2021-01-26 湖南海路生物科技有限公司 用于分离粪便中菌群的智能分离系统
KR102554078B1 (ko) * 2020-12-08 2023-07-10 건국대학교 산학협력단 애완동물을 위한 대사체 전환능 기반 유산균 조합 정보 제공 장치 및 방법
EP4228427A1 (en) 2020-12-11 2023-08-23 Société des Produits Nestlé S.A. Compositions and methods for pet food
CN114437959B (zh) * 2021-11-29 2022-11-18 内蒙古普泽动保生物技术有限公司 一种动物双歧杆菌及其在抗氧化和提升免疫中的应用
US20230165281A1 (en) 2021-11-29 2023-06-01 Société des Produits Nestlé S.A. Methods and compositions for providing a health benefit in an animal
US20230165277A1 (en) 2021-11-29 2023-06-01 Société des Produits Nestlé S.A. Methods and compositions for providing a health benefit in an animal
WO2023104887A1 (en) * 2021-12-09 2023-06-15 Société des Produits Nestlé S.A. Lactobacillus acidophilus to increase agmatine production by microbiota
CN114292779A (zh) * 2021-12-22 2022-04-08 清远西周生物医药科技有限公司 一种副干酪乳杆菌冻干粉、其应用及制备方法
IT202200013138A1 (it) * 2022-06-22 2023-12-22 Cerbios Pharma Sa Probiotico per l’uso nel trattamento di alterazioni infiammatorie della mucosa intestinale, in particolare obesità
WO2024057113A1 (en) 2022-09-13 2024-03-21 Societe Des Produits Nestle Sa Methods for providing and determining an efficacious weight loss diet for a canine
US20240081374A1 (en) 2022-09-14 2024-03-14 Société des Produits Nestlé S.A. Compositions and methods utilizing southern ocean mackerel oil for providing health benefits in an animal
KR102554206B1 (ko) * 2022-12-01 2023-07-13 (주)에이앤바이오 구강 항산화 증진을 통한 반려동물 치석 제거, 구취 개선, 잇몸 보호에 도움을 주는 카탈라아제 함유 반려동물 구강 건강 증진용 조성물
CN116333922A (zh) * 2023-02-10 2023-06-27 宁波希诺亚海洋生物科技有限公司 一株来源于深海大鱿鱼的鼠李糖乳杆菌菌株及其应用
KR102625196B1 (ko) * 2023-04-19 2024-01-15 박종호 기호도가 우수한 반려동물용 유산균 영양제 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160038A (en) * 1976-08-09 1979-07-03 Microlife Technics, Inc. Lactic acid fermentate flavored pet food
JPH07194317A (ja) * 1993-12-29 1995-08-01 Nichinichi Seiyaku Kk ペットフード
AUPM823094A0 (en) 1994-09-16 1994-10-13 Goodman Fielder Limited Probiotic compositions
DE29724815U1 (de) * 1997-01-09 2004-07-22 Société des Produits Nestlé S.A. Probiotik enthaltendes Getreideprodukt
US5986569A (en) * 1997-03-20 1999-11-16 Micron Communications, Inc. Radio frequency identification system, radio frequency identification device package, and method of use of radio frequency identification device
WO1999017788A1 (en) * 1997-10-06 1999-04-15 Abbott Laboratories Composition of treatment of candidiasis
US5902743A (en) * 1998-03-20 1999-05-11 Wisconsin Alumni Research Foundation Probiotic bifidobacterium strain
JP4227690B2 (ja) * 1998-10-29 2009-02-18 株式会社バイオテックジャパン ペットフード
EP1034787A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
CZ20013269A3 (cs) * 1999-03-11 2002-04-17 Société des Produits Nestlé S. A. Bakterie mléčného kvaąení
BR0111275B1 (pt) * 2000-05-25 2013-06-18 uso de probiàtico para preparar composiÇço para regular o sistema imune, composiÇço alimentÍcia para animais de estimaÇço, e complemento de dieta.

Also Published As

Publication number Publication date
NO20025528D0 (no) 2002-11-18
DE60127731T2 (de) 2007-08-16
PL207930B1 (pl) 2011-02-28
WO2001090311A1 (en) 2001-11-29
US8124070B2 (en) 2012-02-28
NZ523010A (en) 2004-06-25
EA200201284A1 (ru) 2003-06-26
KR20030010633A (ko) 2003-02-05
IL152695A0 (en) 2003-06-24
ES2262667T3 (es) 2006-12-01
DE60119515T2 (de) 2007-05-24
EP1290136B1 (en) 2006-05-10
BR0111275B1 (pt) 2013-06-18
US7771982B2 (en) 2010-08-10
JP4343477B2 (ja) 2009-10-14
MXPA02011595A (es) 2003-03-27
AU2001278432B2 (en) 2007-08-30
KR100796963B1 (ko) 2008-01-22
US20070178079A1 (en) 2007-08-02
US8771675B2 (en) 2014-07-08
PL359182A1 (en) 2004-08-23
BR0111275A (pt) 2003-06-10
US20080171106A1 (en) 2008-07-17
NO20025528L (no) 2002-12-18
DE60119515D1 (de) 2006-06-14
US20050106133A1 (en) 2005-05-19
EP1541673B1 (en) 2007-04-04
NO330276B1 (no) 2011-03-21
CA2409286A1 (en) 2001-11-29
CN100396769C (zh) 2008-06-25
HU230800B1 (hu) 2018-06-28
CA2409286C (en) 2012-05-15
EP1541673A1 (en) 2005-06-15
HUP0301939A2 (hu) 2003-09-29
IL152695A (en) 2010-02-17
DE60127731D1 (de) 2007-05-16
US20100266549A1 (en) 2010-10-21
EP1290136A1 (en) 2003-03-12
US7381406B2 (en) 2008-06-03
ES2284089T3 (es) 2007-11-01
ZA200210302B (en) 2004-03-19
JP2009096811A (ja) 2009-05-07
MY138070A (en) 2009-04-30
JP4456649B2 (ja) 2010-04-28
JP2003534003A (ja) 2003-11-18
AU7843201A (en) 2001-12-03
US20030190309A1 (en) 2003-10-09
EA006428B1 (ru) 2005-12-29
AR029100A1 (es) 2003-06-04
HUP0301939A3 (en) 2004-04-28
ATE325864T1 (de) 2006-06-15
US7189390B2 (en) 2007-03-13
UY26734A1 (es) 2001-11-30
CN1444647A (zh) 2003-09-24

Similar Documents

Publication Publication Date Title
PE20020232A1 (es) Bacterias acido lacticas como lactobacillus, bifidobacterium y streptococcus aisladas por su potencial probiotico para aplicaciones de alimento de mascotas
Presti et al. Evaluation of the probiotic properties of new Lactobacillus and Bifidobacterium strains and their in vitro effect
Ranadheera et al. Effect of dairy probiotic combinations on in vitro gastrointestinal tolerance, intestinal epithelial cell adhesion and cytokine secretion
Bernardeau et al. Safety and efficacy of probiotic lactobacilli in promoting growth in post-weaning Swiss mice
Ljungh et al. Isolation, selection and characteristics of Lactobacillus paracasei subsp. paracasei F19
Iyer et al. Probiotic properties of folate producing Streptococcus thermophilus strains
Melia et al. Selection of buffalo milk lactic acid bacteria with probiotic potential
RU2013126599A (ru) Нереплицирующиеся пробиотические микроорганизмы, защищающие против инфекций верхних дыхательных путей
DK0768375T3 (da) Mælkesyrebakterier
Grześkowiak et al. Pathogen exclusion properties of canine probiotics are influenced by the growth media and physical treatments simulating industrial processes
Paik et al. Characterization of Bacillus polyfermenticus SCD for oral bacteriotherapy of gastrointestinal disorders
RU2013126602A (ru) Нереплицирующиеся пробиотические микроорганизмы, защищающие детей против желудочно-кишечных инфекций
Millette et al. Characterization of probiotic properties of Lactobacillus strains
Suomalainen et al. In vitro and in vivo gastrointestinal survival, antibiotic susceptibility and genetic identification of Propionibacterium freudenreichii ssp. shermanii JS
Maity et al. Development of healthy whey drink with Lactobacillus rhamnosus, Bifidobacterium bifidum and Propionibacterium freudenreichii subsp. shermanii
Hoda Probiotics bacteria from Egyptian infants cause cholesterol removal in media and survive in yoghurt
Dastoor et al. Probiotics for life–Part I general health perspectives
Lee et al. Potential probiotic properties of Lactococcus lactis NK34 isolated from jeotgal
Mirnejad et al. Reduction of enterotoxigenic Escherichia coli colonization by the oral administration of Lactobacillus casei as a probiotic in a murine model
Mishra et al. Isolation and characterization of probiotic microorganism from fermented dairy products
Ali et al. Isolation, identification and characterization of lactic acid bacteria from traditional yogurt
Pirarat et al. In Vitro efficacy of human-derived probiotic, Lactobacillus rhamnosus against pathogenic bacteria in fish and frogs
Hindal et al. Estimating the inhibitory effect of Lactobacillus isolated from vagina against some pathogens of genital infections in group of women.
Baie et al. Lactobacilli From Buffalo Milk and Yogurt With Antibacterial Activity Against Gram-Negative Uropathogens
Shekhar et al. Probiotics as a Health Supplement

Legal Events

Date Code Title Description
FC Refusal